Related Experiment Video

Updated: Jun 22, 2025

An In Ovo Model for Testing Insulin-mimetic Compounds
06:09

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

10.6K

Putative mechanism of a multivitamin treatment against insulin resistance

José Antonio Palma-Jacinto1, Edgar López-López2,3, José Luis Medina-Franco2

  • 1Laboratory of Biochemistry and Neurotoxicology, Faculty of Bioanalysis-Xalapa, Universidad Veracruzana, Médicos y Odontólogos S/N Unidad del Bosque, Xalapa, Mexico.

Adipocyte
|June 28, 2024
PubMed

Insights

Vitamins A, B, C, D3, and E show anti-inflammatory effects by inhibiting key pathways in insulin resistance. This research explores vitamin mechanisms against nuclear factor kappa B and mitogen-activated protein kinase.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Nutritional Science

Background:

  • Insulin resistance stems from proinflammatory cytokines in adipose tissue, driven by lipid accumulation.
  • The inflammatory pathway involves critical targets: nuclear factor kappa B (NF-κB), inhibitor of nuclear factor κ-B kinase (IKK), and mitogen-activated protein kinase (MAPK).
  • Vitamins possess anti-inflammatory properties, but their precise mechanisms in insulin resistance are not fully understood.

Purpose of the Study:

  • To elucidate the potential mechanisms of vitamins within the inflammatory pathway of insulin resistance.
  • To investigate the inhibitory effects of various vitamins on key inflammatory targets.

Main Methods:

  • Integrated data mining and analysis.
  • Utilized target prediction algorithms.
  • Performed molecular docking simulations to validate interactions.

Main Results:

  • Vitamins A, B1, B2, B3, B5, B6, B7, B12, C, D3, and E were found to inhibit NF-κB and MAPK.
  • Vitamins A and B12 specifically demonstrated inhibitory activity against IKK.
  • These findings suggest a multitarget inhibitory action of vitamins on the inflammatory cascade.

Conclusions:

  • Vitamins exhibit significant potential as anti-inflammatory agents in the context of insulin resistance.
  • A multitarget therapeutic strategy utilizing vitamins could offer a novel approach to managing insulin resistance.
  • Further research is warranted to confirm the inhibitory roles of vitamins against NF-κB, MAPK, and IKK in insulin-resistant models.
Keywords:
Inflammationinsulin resistancemultitargetpolypharmacologyvitamins

More Related Videos

Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion08:22

Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion

Published on: March 20, 2017

8.7K
Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes08:03

Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes

Published on: June 25, 2017

20.0K

Related Concept Videos

Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
188
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
165
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
180
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.9K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
3.2K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.2K